Resource Hub
VIRTUAL TOUR
CONTACT US
Our Company
About Us
Our Journey
Leadership
Scientific and BD Team
Aragen Advantage
Global Locations
Media & Events
Recognitions
Services
Small Molecules
Discovery (CRO)
Integrated Drug Discovery
Chemistry
Biology
BioSafety
Development & Manufacturing (CDMO)
Drug Substance
Drug Product
Analytical Development
Performance Chemicals
Custom Chemical Synthesis
Commercial Manufacturing
Large Molecules (Biologics)
Discovery (CRO)
Integrated Discovery
Biology
Molecular Biology
Antibody Discovery
Protein Sciences
Cell Line Development
Development & Manufacturing (CDMO)
Process Research & Development
Bioproduction
Developability & Analytics
GMP Manufacturing
Investors
Annual Reports and Annual Returns
Corporate Governance
IPO Documents
Our Responsibility
Digital & AI (DnA)
EHS & Sustainability
Strategic Supply Chain Management
Quality
IP Protection & Data Security
Employee Welfare
Corporate Social Responsibility
Corporate Governance
Careers
Working at Aragen
Career Opportunities
Meet Our People
Caution Notice
Virtual Tour
Resources
Close Search
Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
GET IN TOUCH
Financial Information
Company
Aragen Life Sciences Limited
ALSL Audited Standalone financial statements FY26
ALSL Audited Standalone financial statements FY25
ALSL Audited Standalone financial statements FY24
Material Subsidiaries
Aragen Bioscience, Inc.
ABI Audited Standalone financial statements FY 24 to FY 26
Aragen Biologics Private limited
ABPL Audited Standalone financial statements FY 26
ABPL Audited Standalone financial statements FY 25
ABPL Audited Standalone financial statements FY 24
Learn more about our end-to-end capabilities
+
+
